Contingent negative variation in children with anorexia nervosa

Pediatrics International

Volumn 41, Issue 3, 1999, Pages 285-291

  Torigoe, Katsumi ^a   Numata, Osamu ^a   Sato, Takashi ^a   Imai, Chihaya ^a   Takeuchi, Kazuo ^a   Yamazaki, Hajime ^a   Hotta, Hiromitsu ^a   Boku, Naoki ^a   Yazaki, Satoshi ^a   Sudo, Shyoji ^a   Kuwabara, Atsushi ^a   Hasegawa, Satoshi ^a   Hiura, Makoto ^a   Ino, Haruyoshi ^a  

^a NAGAOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Anorexia nervosa; Catecholamine; Cognitive processes; Contingent negative variation

Indexed keywords

NORADRENALIN;

ADOLESCENT; ANOREXIA NERVOSA; APPETITE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CATECHOLAMINE BRAIN LEVEL; CLINICAL ARTICLE; COGNITION; CONTINGENT NEGATIVE VARIATION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD; STIMULUS RESPONSE;

EID: 0032977744     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.1999.t01-1-01071.x     Document Type: Article

References (63)

1. 1 Garattini S, Bizzi A, Caccia S, Mennini T. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline. Int. J. Obes. Relat. Metab. Disord. 1992; 16: S43-50.
2. 2 Hillyard SA. The CNV and human behavior: A review. Electroencephalogr. Clin. Neurophysiol. 1973; 33: 161-71.
3. 3 Lang W, Lang M, Kornhuber A, Decke L, Kornhuber HH. Human cerebral potentials and visuomotor learning. Pflugers Archives 1983; 399: 342-4.
4. 4 Tecce JJ. Contingent negative variation and psychological processes in man. Psychol. Bull. 1972; 77: 73-108.
5. 5 Tecce JJ, Cattanach L. Electroencephalography. Urban and Schwartzenberg, Baltimore, 1987.
6. 6 Klein C, Rockstroh B, Cohen R, Berg P. Contingent negative variation (CNV) and determinants of the post-imperative negative variation (PINV) in schizophrenic patients and healthy controls. Schizophr. Res. 1996; 21: 97-110.
7. 7 Chayo-Dichy R, Ostrosky-Solis F, Meneses S, Harmony T, Guevara MA. The late event related potentials CNV and PINV in normal and dyslexic subjects. Int. J. Neurosci. 1990; 54: 347-57.
8. 8 Timsit-Berthier M, Delaunoy J, Koninckx N, Rousseau JC. Slow potential changes in psychiatry. I. Contingent negative variation. Electroencephalogr. Clin. Neurophysiol. 1973; 35: 355-61.
9. 9 Abraham P, Docherty T, Spencer S et al. An international pilot study of CNV in mental illness. Prog. Brain Res. 1980; 54: 535-42.
10. 10 Dongier M, Koninckx N. Present day neurophysiological models of mind-body interaction. Psychother. Psychosom. 1970; 18: 123-9.
11. 11 Low HD, Stoilen L. CNV, EEG in children. Maturational characteristics and findings in the MCD syndrome. Electroencephalogr. Clin. Neurophysiol. 1973; 33: 139-43.
12. 12 Yordanova J, Dumais-Huber C, Rothenberger A, Wocmer W. Frontocortical activity in children with comorbidity of tic disorder and attention-deficit hyperactivity disorder. Biol. Psychiatr. 1997; 41: 585-94.
13. 13 Cohen J. The CNV in children with special reference to learning disabilities. Electroencephalogr. Clin. Neurophysiol. 1973; 33: 250-6.
14. 14 Charles G, Hansenne M. Le potential lent P300: Interets cliniques dans trois pathologies et neurobiologie: Une revue. Encephale 1991; 18: 225-36.
15. 15 Timsit-Berthier M. Contingent negative variation (CNV) in psychopharmacology. Clin. Neurophysiol. 1991; 42: 142-52.
16. 16 Callaway E. Discussion: Towards a pharmacology of information processing. Electroencephalogr. Clin. Neurophysiol. 1991; 42: 173-6.
17. 18 Sumi N, Nano H, Yamahata K, Ohta Y, Fujimoto O. Contingent negative variation (CNV) and postimperative negative variation (PINV) in schizophrenic patients. Clin. Electroencephalogr. 1989; 31: 145-50.
18. 19 Hoebel BG. Brain neurotransmitters in food and drug reward. Am. J. Clin. Nutr. 1985; 42: 1133-50.
19. 20 Avraham Y, Bonne O, Berry EM. Behavioral and neurochemical alterations caused by diet restriction: The effect of tyrosine administration in mice. Brain Res. 1996; 732: 133-44.
20. 21 Walter WG, Cooper R, Aldridjic VJ, McCallum WC, Winter AL. Contingent negative variation: An electric sign of sensorimotor association and expectancy in the human brain. Nature 1964: 203: 380-4.
21. 22 Weate SJ, Newell SA, Bogner JE, Andrews JM, Drake Jr ME. Contingent negative variation in Gilles de la Tourette syndrome. Clin. Electroencephalogr. 1993; 24: 188-91.
22. 23 Brunia CHM, Damen EJP. Distribution of slow brain potentials related to motor preparation and stimulus anticipation in a time estimation task. Electroencephalogr. Clinc. Neurophysiol. 1988; 69: 234-43.
23. 24 Roth WT, Duncan CC, Pfefferbaum A, Timsit-Berthier M. Applications of cognitive ERPs in psychiatric patients. Electroencephalogr. Clin. Neurophysiol. (Suppl.) 1986; 38: 419-38.
24. 25 Tecce JJ. Dopamine and CNV: Studies of drugs, disease and nutrition. Electroencephalogr. Clin. Neurophysiol. 1991; (Suppl.) 42: 153-64.
25. 26 el Massioui F, Lesevre N. Attention impairment and psychomotor retardation in depressed patients: An event-related potential study. Neurophysiol. Clin. 1988; 70: 46-55.
26. 27 Robert CS, Tecce JJ, Marczynski TJ, Pirch JH, Thompson JW. Neural anatomy, chemistry and event-related brain potentials: An approach to understanding the substrates of mind. Electroencephalogr. Clin. Neurophysiol. (Suppl.) 1986; 38: 343-92.
27. 28 Oishi M, Mochizuki C, Du C, Takasu T. Contingent negative variation and movement-related cortical potentials in Parkinsonism. Electroencephalogr. Clin. Neurophysiol. 1995; 95: 346-9.
28. 29 Tsuda T. Contingent negative variation in parkinsonism: Studies recorded during stereotactic VL thalamotomy. Tokushima J. Exp. Med. 1982; 29: 87-94.
29. 30 Marczynski TJ. A model of brain function. Electroencephalogr. Clin. Neurophysiol. 1986; (Suppl. 38) 351-67.
30. 31 Timsit-Berthier M. Contingent negative variation (CNV) in psychiatry. Electroencephalogr. Clin. Neurophysiol. 1986; (Suppl. 38.) 429-34.
31. 32 Marczynski TJ. A parsimonious model of mammalian brain and event-related slow potentials In: Otto DA (ed). Multidisciplinary Perspectives in Event-related Brain Potential Research. Government Printing Office, Washington, 1978; 626-34.
32. 33 Kaye WH, Ebert MH, Raleigh M, Lake CR. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch. Gen. Psychiatr. 1984; 41: 350-5.
33. 34 Riederer P, Toifl K, Kruzik P. Excretion of biogenic amine metabolites in anorexia nervosa. Clin. Chim. Acta 1982; 123: 27-32.
34. 35 Gross HA, Lake CR, Ebert MH, Ziegler MG, Kopin IJ. Catecholamine metabolism in primary anorexia nervosa. J. Clin. Endocrinol. Metab. 1979; 49: 805-9.
35. 36 Pirke KM. Central and peripheral noradrenalin regulation in eating disorders. Psychiatr. Res. 1996; 62: 43-9.
36. 37 Ericsson M, Poston II WS, Foreyt JP. Common biological pathways in eating disorders and obesity. Addict. Behav. 1996; 21: 733-43.
37. 38 Brewerton TD. Toward a unified theory of serotonin disturbances in eating and related disorders. Psychoneuroendocrinology 1995; 20: 561-90.
38. 39 Gerner RH, Gwirtsman HE. Abnormalities of dexamethasone suppression test and urinary MHPG in anorexia nervosa. Am. J. Psychiatr. 1981; 138: 650-3.
39. 40 Halmi KA, Dekirmenjian H, Davis JM, Casper R, Goldberg S. Catecholamine metabolism in anorexia nervosa. Arch. Gen. Psychiatr. 1978; 35: 458-60.
40. 41 Abraham SF, Beumont PJV, Cobbin DM. Catecholamine metabolism and body weight in anorexia nervosa. Br. J. Psychiatr. 1981; 138: 244-7.
41. 42 Russell GFM. The nutritional disorder in anorexia nervosa. J. Psychosom. Res. 1967; 11: 141-9.
42. 43 Kaye WH, Ballenger JC, Lydiard B et al. CSF monoamine oxidase levels in normal-weight bulimia: Evidence for abnormal noradrenergic activity. Am. J. Psychiatr. 1990; 147: 225-9.
43. 44 Bocker KB, Timsit-Berthier M, Schoenen J, Brunia CH. Contingent negative variation in migraine. Headache 1990; 9: 604-9.
44. 45 Maertens de Noordhout A, Timsit-Berthier M, Schoenen J. Contingent negative variation in headache. Ann. Neurol. 1985; 1: 78-80.
45. 46 Schoenen J, Timsit-Berthier M, Timsit M. Correlations between contingent negative variation and plasma levels of catecholamine in headache patients. Cephalalgia (Suppl.) 1985; 5: 480.
46. 47 Schoenen J, Maertens de Noordhout A, Delwaide PJ. Plasma catecholamines in headache patients: Clinical correlations. Headache (Suppl.) 1985; 5: 28.
47. 48 Besken E, Pothmann R, Sartory G. Contingent negative variation in childhood migraine. Cephalalgia 1993; 13: 42-3.
48. 49 Hsu LKG, Crisp AH, Harding B. Outcome of anorexia nervosa. Lancet 1979; i: 61-5.
49. 50 Morgan H, Russel G. Value of family background and clinical features as predictors of long-term outcome in anorexia nervosa: Four year follow-up study of 41 patients. Psychol. Med. 1975; 5: 355-71.
50. 51 Theander S. Anorexia nervosa. A psychiatric investigation of 94 female patients. Acta Psychiatr. Scand. (Suppl.) 1970; 214: 1-194.
51. 52 Kaye WH, Jimerson DC, Lake CR, Ebert MH. Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa. Psychiatr. Res. 1985; 14: 333-42.
52. 53 Pirke KM, Kellner M, Philipp E. Laessle R, Krieg J, Fichter MM. Plasma norepinephrine after a standardized test meal in acute and remitted patients with anorexia nervosa and in healthy controls. Biol. Psychiatr. 1992; 31: 1074-7.
53. 54 Klorman R, Brumaghim JT. Stimulant drugs and ERPs. Electroencephalogr. Clin. Neurophysiol. 1991; 42: 135-141.
54. 55 Rosler F, Manzey D, Sojka B, Stieglitz R. Delineation of pharmacopsycological effects of means of endogenous event-related brain potentials: An exemplification with flupentixol. Neuropsychobiology 1985; 13: 81-92.
55. 56 Tecce JJ, Cole JO, Savignano-Bowman J. Chlorpromazine effects on brain activity (contingent negative variation) and reaction time in normal women. Psychopharmacologia 1975; 43: 293-5.
56. 57 Martineau J, Garreau B, Barthelemy C, Callaway E, LeLord G. Effects of vitamin B6 on averaged evoked potentials in infantile autism. Biol. Psychiatr. 1981; 16: 627-41.
57. 58 Hartmann von Monakow K. The significance of vitamin B6 for neurology. Psychiatr. Neurol. 1961; 142: 387-403.
58. 59 Gerner RH, Cohen DJ, Fairbanks L et al. CSF neurochemistry of women with anorexia nervosa and normal women. Am. J. Psychiatr. 1984; 141: 1441-4.
59. 60 Lefkowitz RJ. Beta-adrenergic receptors: Recognition and regulation. N. Engl. J. Med. 1979; 295: 323-8.
60. 61 Gibson CJ, Wurtman RJ. Physiological control of brain NE synthesis by brain tyrosine concentrations. Biochem. Pharmacol. 1977; 26: 1137-42.
61. 62 Agharanya JC, Alonso R, Wurtman RJ. Changes in catecholamine excretion after short term tyrosine ingestion in normally fed subjects. Am. J. Clin. Nutr. 1981; 34: 82-7.
62. 63 Growdon JH, Melamed E, Logue M, Hefti F, Wurtman RJ. Effects of oral L-tyrosine on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sci. 1982; 30: 827-32.
63. 64 Shurtleff D, Thomas JR, Schrot J, Kowalski K, Harord R. Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacol. Biochem. Behav. 1994; 47: 935-41.